HanBio Therapeutics Announces the Completion of a US$40 Million Series A Financing Led by OrbiMed and Hankang Capital

/PRNewswire/ -- HanBio Therapeutics ("HanBio"), a biotechnology company committed to researching and developing next generation transformative medicines, today...

Related Keywords

China ,Quanhong ,Anhui ,Jing Lou ,Guangdong ,Guojian ,United States ,Shanghai ,Steven Dasong Wang ,Zhenping Zhu ,Research At Imclone Systems ,Sunshine Guojian Pharmaceutical Shanghai Co Ltd ,Sbio Group ,Kadmon Holdings ,Bio Therapeutics ,Hankang Capital ,Yonghua Investment ,Sunshine Guojian Pharmaceutical ,Chief Executive Officer ,Chief Scientific Officer ,Executive Vice President ,Vice President ,Global Head ,Protein Sciences ,Novartis Biologics ,Sunshine Guojian ,Quanhong Yuan ,Hanbio Therapeutics ,